LINQ II™ Insertable Cardiac Monitor

Find answers for your younger patients.

The LINQ II insertable cardiac monitor (ICM) is now available for pediatric patients two years and older.

Why the LINQ II ICM for pediatric patients?

Medtronic remains committed to expanding patient access for insertable cardiac monitors, and is excited to announce that the LINQ II ICM is now available for patients as young as two years old. Insertion of a LINQ II ICM typically takes less than five minutes. It involves making a small < 1 cm incision with a preloaded insertion tool.

If you would like to learn more about the LINQ II ICM and the insertion procedure, please complete this short form to be contacted by a Medtronic representative.

Indicated for patients two years and older.

Young girl in pink in doctor's office sitting on a table smiling and talking to the pediatrician

Cardiac monitoring for pediatric patients

Trust the most accurate ICM1-13 on the market for your pediatric patients.

The LINQ II ICM is the smallest14 insertable cardiac monitor, making it the optimal choice for pediatric patients who need cardiac monitoring. The device delivers 24/7 heart monitoring with no patches or wires in the way, letting kids be kids and granting peace of mind for parents and caregivers. The LINQ II ICM can help your pediatric patients enjoy a better quality of life and get back to their active lifestyle.

Insertable cardiac monitors are useful for monitoring arrhythmias in pediatric patients. As part of a retrospective study, it was reported ICM monitoring led to a change in management in one-third of patients.15

Learn more about the LINQ II ICM.

Find out more about the LINQ II ICM to better manage your younger patients who experience infrequent symptoms that require long-term monitoring or ongoing management.

Stay connected.

Opt in to get the latest updates on ICM products, events, and training.

Training and education

Visit Medtronic Academy to access a variety of training and education resources. Registration and/or login required.

Follow us on social media.

Stay up to date on product updates and events.


™Third-party brands are trademarks of their respective owners.



Pürerfellner H, Sanders P, Sarkar S, et al. Adapting detection sensitivity based on evidence of irregular sinus arrhythmia to improve atrial fibrillation detection in insertable cardiac monitors. Europace. November 2018;20(FI_3):f321-f328.


Nölker G, Mayer J, Boldt L, et al. Performance of an Implantable Cardiac Monitor to Detect Atrial Fibrillation: Results of the DETECT AF Study. J Cardiovasc Electrophysiol. December 2016;27(12):1403-1410.


Confirm Rx™* ICM K163407 FDA clearance letter. 2017.


Confirm Rx ICM K182981 FDA clearance letter. 2019.


Jot Dx™* ICM K212206 FDA clearance letter. 2021.


Monitoring Devices Merlin™* PCS Help Manual for SJM Confirm™*, Confirm Rx ICM, Jot Dx Manual. 2021.


BIOTRONIK BioMonitor™* 2 technical manual. 2017.


BIOTRONIK BIOMONITOR III technical manual. 2020.


BIOTRONIK BIOMONITOR IIIm technical manual. 2020.


BIOTRONIK BIOMONITOR III. K190548 FDA clearance. 2019.


BIOTRONIK BIOMONITOR IIIm. K201865 FDA clearance. 2020.


Lux-Dx™* ICM K212206 FDA clearance letter. 2020.


Lux-Dx ICM user manual. 2020.


ICM Size Comparison Guide. Medtronic data on file. 2021.


Jassal AK, Thomas C, Daniels C, Kertesz NJ, Kamp AN. Detection of arrhythmias in pediatric and congenital heart disease patients with implantable loop recorders. Heart Rhythm. 2018;15(5 Supplement 1):S301.